The new Dutch health insurance system and its implications for pharmaceutical innovation
Year of publication: |
2007
|
---|---|
Authors: | Cohen, Joshua |
Published in: |
International journal of pharmaceutical and healthcare marketing : IJPHM. - Bingley : Emerald, ISSN 1750-6123, ZDB-ID 2364540-4. - Vol. 1.2007, 3, p. 214-225
|
Subject: | Niederlande | Netherlands | Gesetzliche Krankenversicherung | Public health insurance | Krankenversicherung | Health insurance | Pharmaindustrie | Pharmaceutical industry | Innovation | Pharmakologie | Pharmacology |
-
Public health insurance and pharmaceutical innovation : evidence from China
Zhang, Xuan, (2021)
-
Do cost-sharing and entry deregulation curb pharmaceutical innovation?
Grossmann, Volker, (2013)
-
Market size and innovation : effects of Medicare Part D on pharmaceutical research and development
Blume-Kohout, Margaret E., (2013)
- More ...
-
Can egalitarianism survive internationalization?
Cohen, Joshua, (1997)
-
Inequity and intervention : the Federal Budget and Central America
Cohen, Joshua, (1986)
-
The new inequality : creating solutions for poor America
Freeman, Richard B., (1999)
- More ...